BellBrook Labs looks forward to the upcoming SLAS 2026 conference in Boston, Massachusetts. This year’s conference and exhibition theme is Catalyze Discovery, and we’re excited to be involved in the event’s celebration of the interconnectivity of technology and discovery, laboratory automation, innovation and analytics. At SLAS, we plan to exhibit BellBrook’s complete HTS assay solutions […]
BellBrook Labs looks forward to connecting with attendees at the upcoming American Association for Cancer Research® (AACR) Annual Meeting 2025 in Chicago, Illinois. AACR gathers a community of scientists, clinicians, health care providers, and more to showcase and advance the latest cutting-edge technologies for cancer research. Our team of HTS assay and services experts are […]
BellBrook Labs looks forward to connecting with attendees at the upcoming SLAS 2025 conference in San Diego, California. The Society for Laboratory Automation and Screening (SLAS) hosts the SLAS international conference and exhibition to celebrate the latest in technology and discovery as well as laboratory automation and screening. At SLAS, we plan to exhibit our […]
BellBrook Labs looks forward to connecting with attendees at the upcoming AACR 2024 conference in San Diego, California. AACR gathers a community of scientists, clinicians, health care providers, and more to showcase and advance the latest cutting-edge technologies for cancer research. At AACR, we plan to exhibit our complete HTS assay solutions that are designed […]
BellBrook Labs looks forward to connecting with attendees at the upcoming SLAS 2024 conference in Boston, Massachusetts. SLAS is a beacon for the life sciences community, showcasing companies from diverse backgrounds that converge onto the same mission: accelerate life sciences research and technologies. BellBrook plans to contribute to this unified mission by showcasing our cutting-edge […]
BellBrook Labs will exhibit and present posters at the upcoming SLAS 2023 conference in San Diego, California. At the SLAS conference, BellBrook will demonstrate applications for its suite of high throughput screening tools, including residence time determination, targeting kinases involved in the innate immune response, navigating hit prioritization after screening using biochemical assays, assay development, […]
BellBrook Labs will exhibit and present posters at the upcoming SLAS 2022 conference in Boston, MA. At the conference BellBrook will demonstrate applications for its suite of high throughput screening tools, including residence time determination, targeting kinases involved in the innate immune response, navigating hit prioritization after screening using biochemical assays, assay development, lead discovery […]
TREX1 Inhibitor assays could help move things forward for cancer and HIV treatments. – The immune system of humans is remarkable. Unlike the adaptive immune response, the innate immune response is quick and is considered the first line of defense against pathogens and foreign DNA. This foreign material can come from pathogens, tumor cells, or […]
The National Institute of Allergy and Infectious Diseases (NIAID) recently awarded BellBrook Labs a $1.8 million Phase II Small Business Innovative Research (SBIR) grant to develop small molecule antagonists of cyclic GAMP synthase (cGAS). The grant will enable BellBrook to optimize their cGAS lead molecules and test their efficacy for treating lupus-related UV light sensitivity […]
The National Cancer Institute (NCI) recently awarded BellBrook Labs a $300,000 Phase I Small Business Innovative Research (SBIR) grant to develop tools for discovering small-molecule antagonists of TREX1, a checkpoint at the top of the critical immunostimulatory STING pathway. Madison, WI – March 2021 – BellBrook Labs has been awarded a $300,000 Phase I Small […]
BellBrook Labs
1232 Fourier Drive, Suite 115
Madison, Wisconsin 53717 USA
(608) 443-2400
info@bellbrooklabs.com